In consultation: Guidance and quality standards

Skip to filters Skip to results

Showing 1 to 3 of 3

Sort by

Type: GuidanceRemove Type: Guidance filter
Guidance programme: Technology appraisal guidanceRemove Guidance programme: Technology appraisal guidance filter
Guidance programme: Antimicrobial prescribing guidelinesRemove Guidance programme: Antimicrobial prescribing guidelines filter
Guidance programme: Cancer service guidelinesRemove Guidance programme: Cancer service guidelines filter
Guidance programme: Clinical guidelinesRemove Guidance programme: Clinical guidelines filter
Guidance programme: Diagnostics guidanceRemove Guidance programme: Diagnostics guidance filter
Guidance programme: Medicines practice guidelinesRemove Guidance programme: Medicines practice guidelines filter
Guidance programme: Public health guidelinesRemove Guidance programme: Public health guidelines filter
Guidance programme: Safe staffing guidelinesRemove Guidance programme: Safe staffing guidelines filter
Guidance programme: Social care guidelinesRemove Guidance programme: Social care guidelines filter

Guidance and quality standards in consultation
Title	Consultation	Type	Consultation end date
Ruxolitinib for treating acute graft versus host disease refractory to corticosteroids in people aged 12 and over [ID6377]	Draft guidance	Technology appraisal guidance	10 January 2025
Cladribine for treating relapsing multiple sclerosis [ID6263]	Draft guidance	Technology appraisal guidance	9 January 2025
Molnupiravir for treating COVID-19 [ID6340]	Draft guidance	Technology appraisal guidance	17 December 2024

Results per page

10
25
50
All